Skip to content

PALISADE BIO, INC.: 10-K filed 2015-03-16

What PALISADE BIO, INC. reported in its annual report filed 2015-03-16 (fiscal FY 2014): 34 published measures, 113 facts as tagged in accession 0001144204-15-016085.

This filing

Form
10-K (annual report)
Filed
2015-03-16
Fiscal period
fiscal FY 2014
Accession
0001144204-15-016085 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-3129,844,075USD
At 2013-12-3119,413,536USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-3112,124,739USD
At 2013-12-3110,995,337USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-3117,719,336USD
At 2013-12-318,418,199USD
At 2012-12-316,972,633USD
At 2011-12-311,659,818USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-3112,518,980USD
At 2013-12-3116,846,052USD
At 2012-12-317,443,773USD
At 2011-12-312,352,013USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-5,503,168USD92
2014-01-01 to 2014-12-31-22,628,744USD365
2014-07-01 to 2014-09-30-4,455,237USD92
2014-04-01 to 2014-06-30-6,751,282USD91
2014-01-01 to 2014-03-31-5,919,057USD90
2013-10-01 to 2013-12-31-3,303,188USD92
2013-01-01 to 2013-12-31-19,831,862USD365
2013-07-01 to 2013-09-30-6,686,957USD92
2013-04-01 to 2013-06-30-6,251,630USD91
2013-01-01 to 2013-03-31-3,590,087USD90
2012-01-01 to 2012-12-31-10,121,517USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-31207,893USD365
2013-01-01 to 2013-12-31125,362USD365
2012-01-01 to 2012-12-3139,220USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-10-01 to 2014-12-314,666USD92
2014-01-01 to 2014-12-3118,833USD365
2014-07-01 to 2014-09-305,000USD92
2014-04-01 to 2014-06-305,000USD91
2014-01-01 to 2014-03-314,167USD90
2013-10-01 to 2013-12-312,500USD92
2013-01-01 to 2013-12-31110,000USD365
2013-07-01 to 2013-09-302,500USD92
2013-04-01 to 2013-06-302,500USD91
2013-01-01 to 2013-03-31102,500USD90
2012-01-01 to 2012-12-31407,708USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-151,054,781USD
At 2013-12-31-128,426,037USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-12-310USD365
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-31301,265USD
At 2013-12-31230,971USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-314,320,073USD365
2013-01-01 to 2013-12-312,331,401USD365
2012-01-01 to 2012-12-311,610,845USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-4,640,965USD92
2014-01-01 to 2014-12-31-17,435,849USD365
2014-07-01 to 2014-09-30-4,106,745USD92
2014-04-01 to 2014-06-30-3,511,238USD91
2014-01-01 to 2014-03-31-5,176,901USD90
2013-10-01 to 2013-12-31-2,762,573USD92
2013-01-01 to 2013-12-31-12,523,941USD365
2013-07-01 to 2013-09-30-3,633,986USD92
2013-04-01 to 2013-06-30-3,235,602USD91
2013-01-01 to 2013-03-31-2,891,780USD90
2012-01-01 to 2012-12-31-10,156,456USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-3128,161,782USD
At 2013-12-3117,619,119USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,620,776USD365
2013-01-01 to 2013-12-311,394,274USD365
2012-01-01 to 2012-12-312,699USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-314,008,695USD
At 2013-12-315,936,132USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-12-31225,524USD
At 2013-12-3110,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-12-3117,454,682USD365
2013-01-01 to 2013-12-3112,633,941USD365
2012-01-01 to 2012-12-3110,564,164USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-12-318,134,753USD365
2013-01-01 to 2013-12-317,134,301USD365
2012-01-01 to 2012-12-316,105,984USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3187,789,679shares
At 2013-12-3177,886,031shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-12-31167,890,220USD
At 2013-12-31136,058,135USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-12-316,000USD
At 2013-12-317,241USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-31784,497USD
At 2013-12-31577,105USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-31483,232USD
At 2013-12-31346,134USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-12-311,233,172USD
At 2013-12-311,137,701USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-3158,713USD
At 2013-12-3164,897USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2014-12-310USD
At 2013-12-310USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-12-318,971,299USD365
2013-01-01 to 2013-12-315,254,915USD365
2012-01-01 to 2012-12-314,247,037USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-12-31137,000USD365
2013-01-01 to 2013-12-31126,000USD365
2012-01-01 to 2012-12-31101,000USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-01-01 to 2014-12-31211,000USD365
2013-01-01 to 2013-12-31119,000USD365
2012-01-01 to 2012-12-31110,000USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-5,192,895USD365
2013-01-01 to 2013-12-31-7,307,921USD365
2012-01-01 to 2012-12-3134,939USD366

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2014-01-01 to 2014-12-310USD365
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-310USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-5,625,529USD365
2013-01-01 to 2013-12-31-3,933,543USD365
2012-01-01 to 2012-12-31-4,042,898USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-09-01 to 2012-09-307,000,000USD30
2012-08-01 to 2012-08-312,760,000USD31
2012-02-01 to 2012-02-285,200,000USD28

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31215,524USD365
2013-01-01 to 2013-12-316,667USD365
2012-01-01 to 2012-12-31-231,042USD366

Inspect the source

Entity
PALISADE BIO, INC. / CIK 0001357459
Captured
2026-09-20T07:55:46.162Z
SEC response SHA-256
1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))